Abstract
Thyroid diseases present through altered hormone production, diffuse or focal structural abnormalities, and inflammatory processes. Their clinical significance cannot be established from fatigue, weight change, or neck enlargement alone. This narrative review examines hypothyroidism, hyperthyroidism, autoimmune thyroiditis, nodular goiter, and features that raise concern for malignancy. Clinical findings are interpreted alongside thyroid-stimulating hormone, free thyroxine, and additional investigations selected for the presentation. Ultrasonography evaluates structure but does not independently determine hormonal function. Early recognition of emergencies, identification of the cause of thyrotoxicosis, and risk-based assessment of nodules are central to appropriate care. Treatment should reflect the disease mechanism, age, cardiovascular status, and individual circumstances. Follow-up must assess symptoms, laboratory response, medication safety, and quality of life rather than biochemical results in isolation.References
[1] National Institute for Health and Care Excellence. Thyroid disease: assessment and management. NICE guideline NG145. 2019; updated 2023.
[2] Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014;24:1670–1751. doi: 10.1089/thy.2014.0028.
[3] Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26:1343–1421. doi: 10.1089/thy.2016.0229.
[4] Kahaly GJ, Bartalena L, Hegedüs L, et al. 2018 European Thyroid Association guideline for the management of Graves’ hyperthyroidism. European Thyroid Journal. 2018;7:167–186. doi: 10.1159/000490384.
[5] Bartalena L, Kahaly GJ, Baldeschi L, et al. The 2021 EUGOGO clinical practice guidelines for the medical management of Graves’ orbitopathy. European Journal of Endocrinology. 2021;185:G43–G67. doi: 10.1530/EJE-21-0479.
[6] European Thyroid Association. 2023 European Thyroid Association clinical practice guidelines for thyroid nodule management. European Thyroid Journal. 2023;12:e230067. doi: 10.1530/ETJ-23-0067.